Wednesday, January 9, 2013 Tuesday, January 8, 2013- Top Bullish Stock On Tuesday: Celgene With Unusual Call Activitiesat Seeking Alpha (Tue, Jan 8)
- One-on-One with Canaan Partners' Wende Hutton on startup Labrys Biologicsat bizjournals.com (Tue, Jan 8)
- Amgen Agrees to Deal with Bind to Develop Cancer Drugsat Bloomberg (Tue, Jan 8)
- Biotech Grudge Match: Game, Set, & Match?at Motley Fool (Tue, Jan 8)
- [video] Revisions & Reversalsat CNBC (Tue, Jan 8)
- Amgen Licenses Nanopartical Technology to Improve Cancer Drugat Motley Fool (Tue, Jan 8)
- [video] Tweet 'Fast Money' Your Favorite Airline Stockat CNBC (Tue, Jan 8)
- Biogen Submits Hemophilia B BLAZacks (Tue, Jan 8)
- Bind and Amgen in $180M cancer drug research dealAP (Tue, Jan 8)
- J.P. Morgan Healthcare Confab Live Blog Day Twoat TheStreet (Tue, Jan 8)
- Healthcare ETF Attempts Breakout to All-Time HighsETF Trends (Tue, Jan 8)
- BIND Biosciences inks $180M deal with Amgenat bizjournals.com (Tue, Jan 8)
- Celgene Most Impressive On Day 1 of J.P. Morgan Healthcare Confabat TheStreet (Tue, Jan 8)
Monday, January 7, 2013Add AMGN News to My Yahoo!  | |
|